AI in drug discovery

News

Google has said it will release new open-source AI models for drug discovery, TxGemma, through a developers' programme later this month.

News

Insilico Medicine has raised $110 million in Series E funding for its artificial intelligence-powered drug discovery operations.

News

Lila Sciences has emerged with $200m in seed financing to advance its vision of AI-powered, fully autonomous labs to power scientific advances.

News

Owkin has partnered 20 healthcare institutions on a patient data mining project, ATLANTIS, across oncology, immunology/inflammation, and neurology.

News

Another AI drug discovery venture has emerged from the Google DeepMind team, Latent Labs, with $50m in funding for its protein design platform.

News

Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI.